Product analysis
Wellness ImmuNitric combines B vitamins with arginine and citrulline for nutritional and blood-flow support. The arginine offers good value, while citrulline is expensive for the amount supplied.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
The relative quality of the named vitamin and arginine forms remains uncertain. Citrulline's form is unnamed, limiting a clear comparison of that ingredient.
Ingredient Transparency63
All listed amounts are disclosed, but several ingredient forms are missing. Folate comes from a mixture whose proportions are not given, leaving its full composition unclear.
Value For Money44
Arginine offers good value, while citrulline is expensive for the amount supplied. Uncertain value for the vitamins and other ingredients prevents a clear cost judgment for the complete formula.
Customer Satisfaction68
The available ratings are generally positive, but they come from a small group of customers. That gives only a limited view of satisfaction and does not establish improved energy or circulation.
Product Focus68
The B vitamins support normal nutritional functions, while the amino acids have a separate blood-flow purpose. Evidence for routine vascular and performance benefits is inconsistent, especially for the small citrulline contribution.
- Format
Powder - Container
- 8 Ounce(s)
- Per serving
- $0.61
- Customer rating
- 4.6 · 27 ratings
Goals
Folate and vitamin B6 support homocysteine metabolism, but lowering homocysteine does not automatically reduce cardiovascular events. Declared arginine supplies a nitric-oxide precursor, although routine blood-pressure benefits are not established. Citrulline is present in a small amount. A separate L-arginine entry remains unresolved and cannot be treated as an additional dose.
How this product is rated for Cardiovascular Support
Ingredient fit71
Goal fit
Dose adequacy
Pathways49
Depth
Breadth
Evidence74
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Folate and vitamin B6 support normal nutrient functions and can help address tiredness associated with low intake. Arginine and L-citrulline contribute to the saved blood-flow findings, but arginine's performance evidence is inconsistent and citrulline findings are exercise-specific. The small pure L-citrulline amount should not inherit results from larger citrulline-malate exposures. Nutritional support and exercise effects remain separate expectations.
How this product is rated for Energy
Ingredient fit84
Goal fit
Dose adequacy
Pathways46
Depth
Breadth
Evidence66
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Carbohydrates | 1 Gram(s) | |
Vitamin B6 (Pyridoxine Hydrochloride) | 7.5 mg | |
Folate (Calcium Folinate, Folic Acid) | 425 mcg DFE | |
Sodium | 260 mg | |
L-Arginine (L-Arginine Hydrochloride) | 2400 mg | |
L-Citrulline | 600 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Arginine Form & Sourcing Purity
Dose, Safety & Label Transparency85
Arginine Dose Per Serving
Value80
Price Per Gram of Arginine
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Citrulline Form Specificity
Purity and Sourcing Markers
Dose, Safety & Label Transparency40
L-Citrulline Dosage Efficacy
Label Clarity and Transparency
Value0
Price per Gram of L-Citrulline
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Reassessment of the effect of oral l-arginine on blood pressure: A systematic review and meta-analysis based on ambulatory blood pressure monitoring.
- Effect of Long-Term L-Arginine Supplementation on Arterial Compliance and Metabolic Parameters in Patients with Multiple Cardiovascular risk Factors: Randomized, Placebo-Controlled Study.
- Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials.
- L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease.
- Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial.
- Does l-citrulline supplementation and watermelon intake reduce blood pressure in middle-aged and older adults? A systematic review and meta-analysis of randomized controlled trials.
- Micronutrient Supplementation to Reduce Cardiovascular Risk.
- l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans.
- Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women.
- Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
- Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
- Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
- Effect of folic acid on endothelial function following acute myocardial infarction.
- Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
- 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
- Association between serum pyridoxal 5'-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study.
- Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus.
- Pyridoxine improves endothelial function in cardiac transplant recipients.
- Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
- Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.